Clinical Trials in Chicago

Showing 6581-6600 of 15,574 trials

PNT2258 for Treatment of Patients With Richter's Transformation (Brighton)

NCT02378038

This study is sponsored by Sierra Oncology, Inc. formerly ProNAi Therapeutics, Inc. It is a multi-center, single-arm, 2-stage, open-label phase II investigation of PNT2258 to characterize anti-tumor activity and collect safety data on patients with Richter's Transformation.

Richter's Transformation

Sierra Oncology LLC - a GSK company5 participantsStarted Aug 2015

Orange, California, United States • Chicago, Illinois, United States • Boston, Massachusetts, United States +6 more locations

Active Not RecruitingPhase 42.2 miles

Nasal Decolonization of Dialysis Patients Noses

NCT04210505

Hemodialysis patients are at high-risk for infections, specifically Staphylococcus aureus infections. The investigators propose to 1) implement a novel intervention (nasal povidone-iodine at each hemodialysis session) to prevent S. aureus infections using a stepped-wedge cluster randomized trial, and 2) evaluate the feasibility and acceptability of this intervention. If successful, this intervention can be used among hemodialysis patients, and evaluated in other high-risk patient populations to prevent S. aureus infections.

Staphylococcus Aureus Infection

Marin L. Schweizer, PhD302 participantsStarted Sep 2020

Atlanta, Georgia, United States • Chicago, Illinois, United States • Iowa City, Iowa, United States +2 more locations

PNT2258 for Treatment of Patients With Richter's Transformation (Brighton)

Nasal Decolonization of Dialysis Patients Noses

Find Trials by Condition in Chicago

Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia

Evaluation of ELX/TEZ/IVA in Cystic Fibrosis (CF) Subjects 2 Through 5 Years

Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma

The Pharmacokinetics, Safety, and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less Than 12 Years of Age

The TIME-2b Study: A Study of AKB-9778 (Razuprotafib), a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR)

PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma

Efficacy and Safety of Increasing Doses of DaxibotulinumtoxinA for Injection (DAXI for Injection) in the Treatment of Moderate or Severe Lateral Canthal Lines

Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung Cancer

Sound Quality Comparisons With Different Hearing Aid Couplings and Venting Systems

S1916 Digital Medicine Program for Pain Control in Cancer Patients

A Phase 2b Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP)

A Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopathic Pulmonary Fibrosis

Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes

A Phase 3 Lot to Lot Consistency Study of Live Oral Cholera Vaccine, PXVX0200 in Healthy Adults

Axitinib Given on an Individualized Schedule for Metastatic Renal Cell Cancer

VAXCHORA Pediatric Study to Assess Safety and Immunogenicity

Study of BPZE1 Intranasal Pertussis Vaccine (Administered Via VaxINator(TM)), Prime + Boost, in Healthy Adults

MP1032 Treatment in Patients With Moderate to Severe COVID-19